{"DataElement":{"publicId":"12662779","version":"1","preferredName":"Data Source Organizational Unit Identifier","preferredDefinition":"A sequence of characters used to identify, name, or characterize the laboratory, institute, or consortium that provided the information.","longName":"12662773v1.00:12662774v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"12662773","version":"1","preferredName":"Data Source Organizational Unit","preferredDefinition":"The person or authoritative body who provided the information.:Organizational unit like a laboratory, institute or consortium.","longName":"2521521v1.00:2223452v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2521521","version":"1","preferredName":"Data Source","preferredDefinition":"The person or authoritative body who provided the information.","longName":"C16493","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Data Source","conceptCode":"C16493","definition":"The person or authoritative body who provided the information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E4C5E7B-C108-2A2F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-25","endDate":null,"createdBy":"UMLLOADER_GOMINER","dateCreated":"2006-09-25","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2223452","version":"1","preferredName":"Organizational Unit","preferredDefinition":"Organizational unit like a laboratory, institute or consortium. (caBIO)","longName":"C41167","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Organizational Unit","conceptCode":"C41167","definition":"Organizational unit like a laboratory, institute or consortium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63863B7-B59A-2394-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CSM","dateCreated":"2005-05-03","modifiedBy":"DWARZEL","dateModified":"2023-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F4E73145-96E2-1EC4-E053-731AD00A4671","latestVersionIndicator":"Yes","beginDate":"2023-02-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-02-17","modifiedBy":"FINCHAMB","dateModified":"2023-11-11","changeDescription":null,"administrativeNotes":"2/17/23 Created for PCDC per metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"12662774","version":"1","preferredName":"Organizational Unit Identifier","preferredDefinition":"Organizational unit like a laboratory, institute or consortium._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"12662774v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"AIEOP","valueDescription":null,"ValueMeaning":{"publicId":"12935180","version":"1","preferredName":"Italian Association of Pediatric Hematology and Oncology","longName":"12935180v1.00","preferredDefinition":"A group from Bologna, Italy, comprised mainly of pediatricians, hematologists, oncologists, surgeons, biologists, nurses and psychologists who are devoted to addressing the problems of hematology, oncology and immunology in the child and adolescent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Italian Association of Pediatric Hematology and Oncology","conceptCode":"C168887","definition":"A group from Bologna, Italy, comprised mainly of pediatricians, hematologists, oncologists, surgeons, biologists, nurses and psychologists who are devoted to addressing the problems of hematology, oncology and immunology in the child and adolescent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C61B4A-48F1-2B55-E053-731AD00A7F88","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C61B4A-48F2-2B55-E053-731AD00A7F88","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"BFM-SG","valueDescription":null,"ValueMeaning":{"publicId":"12935182","version":"1","preferredName":"Berlin-Frankfurt-Munster Study Group","longName":"12935182v1.00","preferredDefinition":"A study group formed in 1975 by three individuals, Hansjorg Riehm in Berlin (B), Bernhard Kornhuber in Frankfurt (F) and Gunther Schellong in Munster (M), who initiated the first multicenter BFM trial. The BFM treatment concept was based on an intensive chemotherapeutic approach employing eight different drugs which led to a revolutionary increase in the survival of children and adolescents with acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Berlin-Frankfurt-Munster Study Group","conceptCode":"C168888","definition":"A study group formed in 1975 by three individuals, Hansjorg Riehm in Berlin (B), Bernhard Kornhuber in Frankfurt (F) and Gunther Schellong in Munster (M), who initiated the first multicenter BFM trial. The BFM treatment concept was based on an intensive chemotherapeutic approach employing eight different drugs which led to a revolutionary increase in the survival of children and adolescents with acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C6B636-85AA-4A36-E053-731AD00AD895","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C6B636-85AB-4A36-E053-731AD00AD895","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"COG","valueDescription":null,"ValueMeaning":{"publicId":"2563903","version":"1","preferredName":"Children's Oncology Group","longName":"2563903v1.00","preferredDefinition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Oncology Group","conceptCode":"C39353","definition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6AC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SOKKERL","dateModified":"2023-03-01","changeDescription":"Updated to use Current concept C39353 - this one was retired in EVS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C6BA40-144A-4AC8-E053-731AD00AE5F1","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"DCOG","valueDescription":null,"ValueMeaning":{"publicId":"12935183","version":"1","preferredName":"Dutch Childhood Oncology Group","longName":"12935183v1.00","preferredDefinition":"A collaborating partner in Innovative Therapies for Children with Cancer Consortium (ITCC), a European based consortium to promote the clinical evaluation of new anti-cancer compounds in children with cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dutch Childhood Oncology Group","conceptCode":"C168889","definition":"A collaborating partner in Innovative Therapies for Children with Cancer Consortium (ITCC), a European based consortium to promote the clinical evaluation of new anti-cancer compounds in children with cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C6E2E2-79E9-532F-E053-731AD00AEA20","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C6E2E2-79EA-532F-E053-731AD00AEA20","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"MRC","valueDescription":null,"ValueMeaning":{"publicId":"12935191","version":"1","preferredName":"Medical Research Council","longName":"12935191v1.00","preferredDefinition":"A publicly funded organization that is part of United Kingdom Research and Innovation, and is dedicated to improving human health through world-class medical research.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical Research Council","conceptCode":"C168892","definition":"A publicly funded organization that is part of United Kingdom Research and Innovation, and is dedicated to improving human health through world-class medical research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C6E856-208E-53C3-E053-731AD00AF14B","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C6E856-208F-53C3-E053-731AD00AF14B","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"NOPHO","valueDescription":null,"ValueMeaning":{"publicId":"12935203","version":"1","preferredName":"Nordic Society of Pediatric Haematology and Oncology","longName":"12935203v1.00","preferredDefinition":"A collaborative group formed in 1984 with members from Denmark, Finland, Iceland, Lithuania, Norway and Sweden and whose goal was to secure that all Nordic children suffering from leukemia would receive optimal therapy wherever they lived.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nordic Society of Pediatric Haematology and Oncology","conceptCode":"C168893","definition":"A collaborative group formed in 1984 with members from Denmark, Finland, Iceland, Lithuania, Norway and Sweden and whose goal was to secure that all Nordic children suffering from leukemia would receive optimal therapy wherever they lived.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C6F715-0586-55D3-E053-731AD00ABD59","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C6F715-0587-55D3-E053-731AD00ABD59","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"PPLLSG","valueDescription":null,"ValueMeaning":{"publicId":"12935204","version":"1","preferredName":"Polish Pediatric Leukemia/Lymphoma Study Group","longName":"12935204v1.00","preferredDefinition":"A collaborative group established in 1974 that had the original goal of implementing unified protocols with standardized diagnostic criteria and therapy regimens for Hodgkin's disease and acute lymphoblastic leukemia. The prospects were widened to include non-Hodgkin's lymphomas and acute myelogenous leukemia in 1983.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polish Pediatric Leukemia/Lymphoma Study Group","conceptCode":"C168894","definition":"A collaborative group established in 1974 that had the original goal of implementing unified protocols with standardized diagnostic criteria and therapy regimens for Hodgkin's disease and acute lymphoblastic leukemia. The prospects were widened to include non-Hodgkin's lymphomas and acute myelogenous leukemia in 1983.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C704E9-C91A-57F0-E053-731AD00A678D","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C704E9-C91B-57F0-E053-731AD00A678D","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"SJCRH","valueDescription":null,"ValueMeaning":{"publicId":"12935205","version":"1","preferredName":"St. Jude Children's Research Hospital","longName":"12935205v1.00","preferredDefinition":"The Saint Jude Children's Research Hospital received its NCI designation in 1977 and was awarded status as a comprehensive cancer center by NCI in 2008. Research is focused specifically on childhood cancers, acquired and inherited immunodeficiencies and genetic disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Saint Jude Children's Research Hospital","conceptCode":"C39510","definition":"The Saint Jude Children's Research Hospital received its NCI designation in 1977 and was awarded status as a comprehensive cancer center by NCI in 2008. Research is focused specifically on childhood cancers, acquired and inherited immunodeficiencies and genetic disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7112B-E41F-590A-E053-731AD00A78E8","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"JKNABLE","dateModified":"2024-02-24","changeDescription":null,"administrativeNotes":"2/24/24 per CCDI-Fed (SSandor13), changed VM LN to St. Jude Children's Research Hospital, moved NCIt term name (Saint Jude Children's Research Hospital) as alt VM name. VM only used in PCDC CDE/VD - no form use. jk","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7112B-E420-590A-E053-731AD00A78E8","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"CCLG","valueDescription":null,"ValueMeaning":{"publicId":"12935206","version":"1","preferredName":"Children's Cancer and Leukaemia Group","longName":"12935206v1.00","preferredDefinition":"A children's cancer charity and United Kingdom and Ireland's professional association for those involved in the treatment and care of children with cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Cancer and Leukaemia Group","conceptCode":"C177327","definition":"A children's cancer charity and United Kingdom and Ireland's professional association for those involved in the treatment and care of children with cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C71EF1-91AC-5B01-E053-731AD00A3123","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C71EF1-91AD-5B01-E053-731AD00A3123","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"GPOH","valueDescription":null,"ValueMeaning":{"publicId":"12935214","version":"1","preferredName":"German Society for Pediatric Oncology and Hematology","longName":"12935214v1.00","preferredDefinition":"A research organization in Germany involved in the understanding, diagnosis, treatment and prognosis of pediatric cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"German Society for Pediatric Oncology and Hematology","conceptCode":"C174960","definition":"A research organization in Germany involved in the understanding, diagnosis, treatment and prognosis of pediatric cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C769F0-78DD-66D4-E053-731AD00A3E29","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C769F0-78DE-66D4-E053-731AD00A3E29","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"SSG","valueDescription":null,"ValueMeaning":{"publicId":"12935215","version":"1","preferredName":"Scandinavian Sarcoma Group","longName":"12935215v1.00","preferredDefinition":"A research organization in Scandinavia involved in the understanding, diagnosis, treatment and prognosis of sarcoma in children and adolescents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scandinavian Sarcoma Group","conceptCode":"C174961","definition":"A research organization in Scandinavia involved in the understanding, diagnosis, treatment and prognosis of sarcoma in children and adolescents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C77385-4137-6869-E053-731AD00ADCE6","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C77385-4138-6869-E053-731AD00ADCE6","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"FSG","valueDescription":null,"ValueMeaning":{"publicId":"12935217","version":"1","preferredName":"French Sarcoma Group","longName":"12935217v1.00","preferredDefinition":"A research organization in France involved in the understanding, diagnosis, treatment and prognosis of sarcoma in children and adolescents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"French Sarcoma Group","conceptCode":"C174962","definition":"A research organization in France involved in the understanding, diagnosis, treatment and prognosis of sarcoma in children and adolescents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C77CCD-6F44-6997-E053-731AD00AEE96","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C77CCD-6F45-6997-E053-731AD00AEE96","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"UK","valueDescription":null,"ValueMeaning":{"publicId":"12935488","version":"1","preferredName":"United Kingdom Sarcoma Registry","longName":"12935488v1.00","preferredDefinition":"An information system in the United Kingdom designed for the collection, storage, and management of data on persons with sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"United Kingdom Sarcoma Registry","conceptCode":"C174963","definition":"An information system in the United Kingdom designed for the collection, storage, and management of data on persons with sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C79286-252B-6BC2-E053-731AD00AA6C5","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C79286-252C-6BC2-E053-731AD00AA6C5","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"EURO-EWING","valueDescription":null,"ValueMeaning":{"publicId":"12935490","version":"1","preferredName":"EURO-EWING Consortium","longName":"12935490v1.00","preferredDefinition":"A coalition of clinical study groups bringing together active clinicians and scientists in Europe dedicated to improving survival from Ewing sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EURO-EWING Consortium","conceptCode":"C174964","definition":"A coalition of clinical study groups bringing together active clinicians and scientists in Europe dedicated to improving survival from Ewing sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7AA7E-D9D0-7296-E053-731AD00A0142","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7AA7E-D9D1-7296-E053-731AD00A0142","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"ISG","valueDescription":null,"ValueMeaning":{"publicId":"12935491","version":"1","preferredName":"Italian Sarcoma Group","longName":"12935491v1.00","preferredDefinition":"A independent, scientific non-profit association formed in 2002 with the purpose of improving the quality of treatment for sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Italian Sarcoma Group","conceptCode":"C174965","definition":"A independent, scientific non-profit association formed in 2002 with the purpose of improving the quality of treatment for sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7B3DB-583E-73BD-E053-731AD00A27B5","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7B3DB-583F-73BD-E053-731AD00A27B5","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"CRCTU","valueDescription":null,"ValueMeaning":{"publicId":"12935492","version":"1","preferredName":"Cancer Research UK Clinical Trials Unit","longName":"12935492v1.00","preferredDefinition":"A research organization in the United Kingdom specializing in the design and delivery of every aspect of clinical trials of all phases in adults and children, from concept to publication.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Research UK Clinical Trials Unit","conceptCode":"C174966","definition":"A research organization in the United Kingdom specializing in the design and delivery of every aspect of clinical trials of all phases in adults and children, from concept to publication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7B7F5-8BB5-7451-E053-731AD00ADAC9","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7B7F5-8BB6-7451-E053-731AD00ADAC9","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"JACLS","valueDescription":null,"ValueMeaning":{"publicId":"12935495","version":"1","preferredName":"Japan Association of Childhood Leukemia Study","longName":"12935495v1.00","preferredDefinition":"A study group in Japan investigating childhood leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Japan Association of Childhood Leukemia Study","conceptCode":"C168890","definition":"A study group in Japan investigating childhood leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7C71F-7B22-7626-E053-731AD00AA1DC","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7C71F-7B23-7626-E053-731AD00AA1DC","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"JPLSG","valueDescription":null,"ValueMeaning":{"publicId":"12935496","version":"1","preferredName":"Japanese Pediatric Leukemia/Lymphoma Study Group","longName":"12935496v1.00","preferredDefinition":"A study group in Japan investigating pediatric leukemia and lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Japanese Pediatric Leukemia/Lymphoma Study Group","conceptCode":"C168891","definition":"A study group in Japan investigating pediatric leukemia and lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7CB0C-65D5-76B9-E053-731AD00AC894","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7CB0C-65D6-76B9-E053-731AD00AC894","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"SFCE","valueDescription":null,"ValueMeaning":{"publicId":"12935497","version":"1","preferredName":"Societe Francaise de Lutte contre les Cancers et Leucemies de l'Enfant et de l'Adolescent","longName":"12935497v1.00","preferredDefinition":"An association founded in France in 2003 which promotes the organization of care and scientific research in the field of childhood and adolescent cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Societe Francaise de Lutte contre les Cancers et Leucemies de l'Enfant et de l'Adolescent","conceptCode":"C177328","definition":"An association founded in France in 2003 which promotes the organization of care and scientific research in the field of childhood and adolescent cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7D194-4228-777C-E053-731AD00A5611","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7D194-4229-777C-E053-731AD00A5611","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"SOPOBE","valueDescription":null,"ValueMeaning":{"publicId":"12935499","version":"1","preferredName":"Brazilian Society of Pediatric Oncology","longName":"12935499v1.00","preferredDefinition":"A society founded in 1981 committed to improve the prognosis of children and adolescents with cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brazilian Society of Pediatric Oncology","conceptCode":"C177329","definition":"A society founded in 1981 committed to improve the prognosis of children and adolescents with cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7D910-CB0F-789E-E053-731AD00A34F5","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7D910-CB10-789E-E053-731AD00A34F5","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"DFCI","valueDescription":null,"ValueMeaning":{"publicId":"7789447","version":"1","preferredName":"DFCI","longName":"7789447","preferredDefinition":"An institute founded in 1947 in Boston, Massachusetts, committed to providing treatment for adults and children with cancer, and developing cures with cutting-edge research.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dana Farber Cancer Institute","conceptCode":"C177330","definition":"An institute founded in 1947 in Boston, Massachusetts, committed to providing treatment for adults and children with cancer, and developing cures with cutting-edge research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD1265CC-0978-1D55-E053-4EBD850A54EA","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-09-28","modifiedBy":"KNABLEJ","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7DE6B-5896-799C-E053-731AD00AFC67","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"COSS-GPOH","valueDescription":null,"ValueMeaning":{"publicId":"12935500","version":"1","preferredName":"Osteosarcoma Study Group of the German Society of Pediatric Oncology and Hematology","longName":"12935500v1.00","preferredDefinition":"The section of the German Society of Pediatric Oncology and Hematology dedicated to the study of osteosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteosarcoma Study Group of the German Society of Pediatric Oncology and Hematology","conceptCode":"C186743","definition":"The section of the German Society of Pediatric Oncology and Hematology dedicated to the study of osteosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7E427-B7B2-7A53-E053-731AD00A6387","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7E427-B7B3-7A53-E053-731AD00A6387","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"BOCG","valueDescription":null,"ValueMeaning":{"publicId":"12935501","version":"1","preferredName":"Brazilian Group and Scandinavian Group","longName":"12935501v1.00","preferredDefinition":"A cooperative group of individuals working with pediatric osteosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brazilian Group and Scandinavian Group","conceptCode":"C180373","definition":"A cooperative group of individuals working with pediatric osteosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7E988-2411-7B1A-E053-731AD00A40EF","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7E988-2412-7B1A-E053-731AD00A40EF","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"GEIS","valueDescription":null,"ValueMeaning":{"publicId":"12935502","version":"1","preferredName":"Grupo Espanol de Investigacion en Sarcomas","longName":"12935502v1.00","preferredDefinition":"A scientific society formed by professionals from more than sixty medical centers across Spain. This group includes surgeons, pediatricians, oncologic radiation therapy specialists, pathologists and molecular researchers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grupo Espanol de Investigacion en Sarcomas","conceptCode":"C180341","definition":"A scientific society formed by professionals from more than sixty medical centers across Spain. This group includes surgeons, pediatricians, oncologic radiation therapy specialists, pathologists and molecular researchers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7F54B-00FE-7C6F-E053-731AD00AA228","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7F54B-00FF-7C6F-E053-731AD00AA228","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"UCL","valueDescription":null,"ValueMeaning":{"publicId":"12935494","version":"1","preferredName":"University College of London","longName":"12935494v1.00","preferredDefinition":"A public research university located in London, England.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"University College of London","conceptCode":"C174967","definition":"A public research university located in London, England.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C7BBC1-78AB-74B5-E053-731AD00A355D","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C7FD9E-E0FF-7D75-E053-731AD00ACE60","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"IDIPGR","valueDescription":null,"ValueMeaning":{"publicId":"12935504","version":"1","preferredName":"International Diffuse Intrinsic Pontine Glioma Registry Case Report Form Questionnaire","longName":"12935504v1.00","preferredDefinition":"Questions used in the case report forms of the international diffuse intrinsic pontine glioma registry for pediatric cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Diffuse Intrinsic Pontine Glioma Registry Case Report Form Questionnaire","conceptCode":"C180886","definition":"Questions used in the case report forms of the international diffuse intrinsic pontine glioma registry for pediatric cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C801A7-F4EA-7DDA-E053-731AD00A42D7","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C801A7-F4EB-7DDA-E053-731AD00A42D7","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"JCCG","valueDescription":null,"ValueMeaning":{"publicId":"12935522","version":"1","preferredName":"Japan Children's Cancer Group Neuroblastoma Committee","longName":"12935522v1.00","preferredDefinition":"A neuroblastoma-focused committee within the Japan Children's Cancer Group, which is a national clinical research group for childhood cancer that was established in 2014 and comprises more than 200 university, community, regional children's, and general hospitals.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Japan Children's Cancer Group Neuroblastoma Committee","conceptCode":"C192770","definition":"A neuroblastoma-focused committee within the Japan Children's Cancer Group, which is a national clinical research group for childhood cancer that was established in 2014 and comprises more than 200 university, community, regional children's, and general hospitals.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C808A2-B0A1-7EDF-E053-731AD00ADA2F","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C808A2-B0A2-7EDF-E053-731AD00ADA2F","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"JNBSG","valueDescription":null,"ValueMeaning":{"publicId":"12937991","version":"1","preferredName":"Japan Neuroblastoma Study Group","longName":"12937991v1.00","preferredDefinition":"A study group established in 2006 with the aims of improving the cure rate of childhood neuroblastoma in Japan and minimizing the late effects of certain treatments.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Japan Neuroblastoma Study Group","conceptCode":"C192771","definition":"A study group established in 2006 with the aims of improving the cure rate of childhood neuroblastoma in Japan and minimizing the late effects of certain treatments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C87B92-16F8-2024-E053-731AD00AEAE2","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C87B92-16F9-2024-E053-731AD00AEAE2","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"SIOPEN","valueDescription":null,"ValueMeaning":{"publicId":"12938072","version":"1","preferredName":"International Society of Paediatric Oncology Europe Neuroblastoma Group","longName":"12938072v1.00","preferredDefinition":"An internationally collaborative research network that brings together physicians, scientists, and other healthcare professionals from across Europe and beyond who are actively involved in the care of patients with, or research into, neuroblastoma to improve patient outcomes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Society of Paediatric Oncology Europe Neuroblastoma Group","conceptCode":"C192772","definition":"An internationally collaborative research network that brings together physicians, scientists, and other healthcare professionals from across Europe and beyond who are actively involved in the care of patients with, or research into, neuroblastoma to improve patient outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C8F6B4-C3A9-3539-E053-731AD00A0FEF","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C8F6B4-C3AA-3539-E053-731AD00A0FEF","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"EpSSG","valueDescription":null,"ValueMeaning":{"publicId":"12938087","version":"1","preferredName":"European Paediatric Soft Tissue Sarcoma Study Group","longName":"12938087v1.00","preferredDefinition":"An international organization of healthcare professionals devoted to the care and treatment of children and young people with soft tissue sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Paediatric Soft Tissue Sarcoma Study Group","conceptCode":"C192774","definition":"An international organization of healthcare professionals devoted to the care and treatment of children and young people with soft tissue sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C90A97-C393-378C-E053-731AD00A9A9C","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C90A97-C394-378C-E053-731AD00A9A9C","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"SIOP MMT","valueDescription":null,"ValueMeaning":{"publicId":"12938088","version":"1","preferredName":"International Society of Paediatric Oncology Malignant Mesenchymal Tumour Committee","longName":"12938088v1.00","preferredDefinition":"An international pediatric oncology committee that specializes in the research of malignant mesenchymal tumors. Along with the Associazione Italiana Ematologia Oncologia Pediatrica-Soft Tissue Sarcoma Committee (AIEOP-STSC), which was formerly known as the Italian Cooperative Group (ICG), SIOP-MMT founded the European pediatric Soft tissue sarcoma Study Group (EpSSG) and the Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) study in 2005 with the goal of making pediatric non-rhabdomyosarcoma soft tissue sarcoma treatment uniform across Europe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Society of Paediatric Oncology Malignant Mesenchymal Tumour Committee","conceptCode":"C192775","definition":"An international pediatric oncology committee that specializes in the research of malignant mesenchymal tumors. Along with the Associazione Italiana Ematologia Oncologia Pediatrica-Soft Tissue Sarcoma Committee (AIEOP-STSC), which was formerly known as the Italian Cooperative Group (ICG), SIOP-MMT founded the European pediatric Soft tissue sarcoma Study Group (EpSSG) and the Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) study in 2005 with the goal of making pediatric non-rhabdomyosarcoma soft tissue sarcoma treatment uniform across Europe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C9129C-0001-3904-E053-731AD00A2553","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C9129C-0002-3904-E053-731AD00A2553","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"CWS","valueDescription":null,"ValueMeaning":{"publicId":"12938089","version":"1","preferredName":"Cooperative Weichteilsarkom Studiengruppe","longName":"12938089v1.00","preferredDefinition":"An international pediatric soft tissue sarcoma study group, also known as the Cooperative Soft Tissue Sarcoma Group, that creates guidance for risk-adapted treatment of soft tissue sarcoma and soft tissue tumors in children, adolescents, and young adults in Europe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cooperative Weichteilsarkom Studiengruppe","conceptCode":"C192777","definition":"An international pediatric soft tissue sarcoma study group, also known as the Cooperative Soft Tissue Sarcoma Group, that creates guidance for risk-adapted treatment of soft tissue sarcoma and soft tissue tumors in children, adolescents, and young adults in Europe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C91721-7EF7-3975-E053-731AD00A337B","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C91721-7EF8-3975-E053-731AD00A337B","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"CBTN","valueDescription":null,"ValueMeaning":{"publicId":"12938090","version":"1","preferredName":"Children's Brain Tumor Network","longName":"12938090v1.00","preferredDefinition":"A network of member institutions affiliated with Children's Hospital of Philadelphia that is involved in the collection of donated brain tumor tissue and other biosamples, and the development cloud-based data platforms, allowing researchers to access brain tumor data and specimen with the shared goal of improving health outcomes for children and young adults with brain tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Brain Tumor Network","conceptCode":"C192778","definition":"A network of member institutions affiliated with Children's Hospital of Philadelphia that is involved in the collection of donated brain tumor tissue and other biosamples, and the development cloud-based data platforms, allowing researchers to access brain tumor data and specimen with the shared goal of improving health outcomes for children and young adults with brain tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C92A04-C091-3C32-E053-731AD00A6CD7","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C92A04-C092-3C32-E053-731AD00A6CD7","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"PNOC","valueDescription":null,"ValueMeaning":{"publicId":"12938091","version":"1","preferredName":"Pacific Pediatric Neuro-Oncology Consortium","longName":"12938091v1.00","preferredDefinition":"An international consortium committed to understanding how brain tumors develop in children, identifying personalized treatment strategies, and improving health outcomes","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pacific Pediatric Neuro-Oncology Consortium","conceptCode":"C192779","definition":"An international consortium committed to understanding how brain tumors develop in children, identifying personalized treatment strategies, and improving health outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C932ED-F7BC-3D30-E053-731AD00A9388","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C932ED-F7BD-3D30-E053-731AD00A9388","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"RBTR","valueDescription":null,"ValueMeaning":{"publicId":"12938092","version":"1","preferredName":"Rare Brain Tumor Registry","longName":"12938092v1.00","preferredDefinition":"An international registry spearheaded by Children’s National Hospital that seeks to create an infrastructure for the prospective collection of biospecimens and radiological and clinical data that would allow better understanding of the biologic mechanisms and therapeutic susceptibilities of childhood rare brain tumors and other rare entities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rare Brain Tumor Registry","conceptCode":"C192780","definition":"An international registry spearheaded by Children's National Hospital that seeks to create an infrastructure for the prospective collection of biospecimens and radiological and clinical data that would allow better understanding of the biologic mechanisms and therapeutic susceptibilities of childhood rare brain tumors and other rare entities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C93DAC-EE15-3EA3-E053-731AD00A0D5A","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C93DAC-EE16-3EA3-E053-731AD00A0D5A","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"SIOPE","valueDescription":null,"ValueMeaning":{"publicId":"12938093","version":"1","preferredName":"European Society for Paediatric Oncology","longName":"12938093v1.00","preferredDefinition":"A pan-European organization representing professionals working in the field of childhood cancers that was originally established in 1998 as the European branch of the International Society of Paediatric Oncology (SIOP) and became an independent organization in 2007.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Society for Paediatric Oncology","conceptCode":"C192781","definition":"A pan-European organization representing professionals working in the field of childhood cancers that was originally established in 1998 as the European branch of the International Society of Paediatric Oncology (SIOP) and became an independent organization in 2007.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C9420B-A110-3FB7-E053-731AD00AFAC0","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C9420B-A111-3FB7-E053-731AD00AFAC0","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"CHLA","valueDescription":null,"ValueMeaning":{"publicId":"12938094","version":"1","preferredName":"Children's Hospital Los Angeles","longName":"12938094v1.00","preferredDefinition":"A nationally ranked, freestanding acute care children's hospital in the East Hollywood district of Los Angeles. Through a network of people and places across Southern California they share standards, knowledge, and people with experienced care partners to ensure that more children receive high-quality, specialized pediatrics.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Hospital Los Angeles","conceptCode":"C192782","definition":"A nationally ranked, freestanding acute care children's hospital in the East Hollywood district of Los Angeles. Through a network of people and places across Southern California they share standards, knowledge, and people with experienced care partners to ensure that more children receive high-quality, specialized pediatrics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C94579-BFDB-4011-E053-731AD00A9C90","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C94579-BFDC-4011-E053-731AD00A9C90","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"DePICT","valueDescription":null,"ValueMeaning":{"publicId":"12938095","version":"1","preferredName":"Defining Platforms for Individualized Cancer Treatment","longName":"12938095v1.00","preferredDefinition":"An IRB approved observational trial opened in 2016 that is designed to monitor outcomes of Broward County, Florida residents with late-stage refractory cancer who undergo next generation sequencing with the goal of targeting the enrollment of underrepresented populations in oncology clinical trials to improve generalizability of clinical research.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Defining Platforms for Individualized Cancer Treatment","conceptCode":"C192784","definition":"An IRB approved observational trial opened in 2016 that is designed to monitor outcomes of Broward County, Florida residents with late-stage refractory cancer who undergo next generation sequencing with the goal of targeting the enrollment of underrepresented populations in oncology clinical trials to improve generalizability of clinical research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C9492F-85A9-40A8-E053-731AD00ADDBA","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C9492F-85AA-40A8-E053-731AD00ADDBA","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"EuRBG","valueDescription":null,"ValueMeaning":{"publicId":"12938096","version":"1","preferredName":"European Retinoblastoma Group","longName":"12938096v1.00","preferredDefinition":"A pan-European partnership between healthcare professionals, families, and patients affected by retinoblastoma with a goal of identifying and developing tools to address the problems with retinoblastoma management through the creation of a retinoblastoma network.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Retinoblastoma Group","conceptCode":"C192785","definition":"A pan-European partnership between healthcare professionals, families, and patients affected by retinoblastoma with a goal of identifying and developing tools to address the problems with retinoblastoma management through the creation of a retinoblastoma network.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C94E54-2207-4158-E053-731AD00A7710","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C94E54-2208-4158-E053-731AD00A7710","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"GALOP","valueDescription":null,"ValueMeaning":{"publicId":"12938097","version":"1","preferredName":"The Latin American Group of Paediatric Oncology","longName":"12938097v1.00","preferredDefinition":"A multinational cooperative group for clinical trials in childhood tumours in Latin America, created in 2008 under the auspices of the Children Oncology group for childhood tumor clinical trials in Latin America.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"The Latin American Group of Paediatric Oncology","conceptCode":"C192786","definition":"A multinational cooperative group for clinical trials in childhood tumours in Latin America, created in 2008 under the auspices of the Children Oncology group for childhood tumor clinical trials in Latin America.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5C95342-65D1-4201-E053-731AD00ABCA9","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5C95342-65D2-4201-E053-731AD00ABCA9","beginDate":"2023-02-28","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-02-28","modifiedBy":"FINCHAMB","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"NRG-Oncology","valueDescription":null,"ValueMeaning":{"publicId":"12939860","version":"1","preferredName":"NRG-Oncology","longName":"12939860v1.00","preferredDefinition":"A leading protocol organization within the National Clinical Trials Network that seeks to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NRG-Oncology","conceptCode":"C177331","definition":"A leading protocol organization within the National Clinical Trials Network that seeks to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5CA4B0A-D631-720F-E053-731AD00AC3DA","latestVersionIndicator":"Yes","beginDate":"2023-02-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-02-28","modifiedBy":"COLBERTM","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5CA4B0A-D632-720F-E053-731AD00AC3DA","beginDate":"2023-02-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-02-28","modifiedBy":"COLBERTM","dateModified":"2023-02-28","deletedIndicator":"No"},{"value":"JINCS","valueDescription":null,"ValueMeaning":{"publicId":"12951420","version":"1","preferredName":"Japanese Infantile Neuroblastoma Collaborative Study Group","longName":"12951420v1.00","preferredDefinition":"A research cooperative based in Japan that conducted studies on infants with stage 1, 2, and 3 neuroblastoma between June 1994 and December 2004.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Japanese Infantile Neuroblastoma Collaborative Study Group","conceptCode":"C192894","definition":"A research cooperative based in Japan that conducted studies on infants with stage 1, 2, and 3 neuroblastoma between June 1994 and December 2004.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5DE12B1-9F6F-51EB-E053-731AD00A8AEF","latestVersionIndicator":"Yes","beginDate":"2023-03-01","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-01","modifiedBy":"COLBERTM","dateModified":"2023-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F5DE12B1-9F70-51EB-E053-731AD00A8AEF","beginDate":"2023-03-01","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-01","modifiedBy":"COLBERTM","dateModified":"2023-03-01","deletedIndicator":"No"},{"value":"C3P","valueDescription":null,"ValueMeaning":{"publicId":"12662905","version":"1","preferredName":"Consortium for Childhood Cancer Predisposition","longName":"12662905v1.00","preferredDefinition":"A multicenter collaborative research group created to improve outcomes for children at high risk for cancer due to hereditary tumor predisposition. It has created a multicenter registry, database, and biorepository for pediatric cancer predisposition syndromes (CPS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Consortium for Childhood Cancer Predisposition","conceptCode":"C192767","definition":"A multicenter collaborative research group created to improve outcomes for children at high risk for cancer due to hereditary tumor predisposition. It has created a multicenter registry, database, and biorepository for pediatric cancer predisposition syndromes (CPS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4E7DCC0-AFB5-3AE2-E053-731AD00AFB42","latestVersionIndicator":"Yes","beginDate":"2023-02-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-02-17","modifiedBy":"COLBERTM","dateModified":"2023-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0CF385EE-2848-7F45-E063-731AD00A99E8","beginDate":"2023-12-20","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-12-20","modifiedBy":"COLBERTM","dateModified":"2023-12-20","deletedIndicator":"No"},{"value":"EORTC","valueDescription":null,"ValueMeaning":{"publicId":"2563904","version":"1","preferredName":"European Organization for Research and Treatment of Cancer","longName":"2563904","preferredDefinition":"European Organization for Research and Treatment of Cancer","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for Research and Treatment of Cancer","conceptCode":"C19741","definition":"A group with aims to conduct, develop, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients' quality of life. There are more than 60 institutions and departments that have been recognized by EORTC as affiliated. These groups conduct, on a voluntary basis, laboratory research and/or clinical trials on all types of cancers using a multidisciplinary approach. EORTC maintains close working relationship with NCI and the British Cancer Research United Kingdom in London.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6AD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0CF385EE-2849-7F45-E063-731AD00A99E8","beginDate":"2023-12-20","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-12-20","modifiedBy":"COLBERTM","dateModified":"2023-12-20","deletedIndicator":"No"},{"value":"SJCRH","valueDescription":null,"ValueMeaning":{"publicId":"14786124","version":"1","preferredName":"St. Jude Children's Research Hospital","longName":"14786124v1.00","preferredDefinition":"The St. Jude Children's Research Hospital received its NCI designation in 1977 and was awarded status as a comprehensive cancer center by NCI in 2008. Research is focused specifically on childhood cancers, acquired and inherited immunodeficiencies and genetic disorders.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"122359E9-D9D3-6CD5-E063-731AD00A24BB","latestVersionIndicator":"Yes","beginDate":"2024-02-24","endDate":null,"createdBy":"JKNABLE","dateCreated":"2024-02-24","modifiedBy":"JKNABLE","dateModified":"2024-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"122359E9-D9D4-6CD5-E063-731AD00A24BB","beginDate":"2024-02-24","endDate":null,"createdBy":"JKNABLE","dateCreated":"2024-02-24","modifiedBy":"JKNABLE","dateModified":"2024-02-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6770742","version":"1","preferredName":"Organizational Unit Identifier","preferredDefinition":"Organizational unit like a laboratory, institute or consortium.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C41167:C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Organizational Unit","conceptCode":"C41167","definition":"Organizational unit like a laboratory, institute or consortium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F97BFC-2AF0-720E-E053-F662850A7E9C","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Incomplete","id":"F4E745F1-ABAB-24AD-E053-731AD00A2185","latestVersionIndicator":"Yes","beginDate":"2023-02-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-02-17","modifiedBy":"JKNABLE","dateModified":"2024-02-24","changeDescription":null,"administrativeNotes":"12/27/23 Change RS to Incomplete pending PV additions/updates per Nov 2023 PCDC-U of Chicago/Mei Li, part of Ped Cancer Core CDEs. jk;  12/20/23 Removed 2 PVs and added 2 other PVs per PCDC. mr;  3/1/23 Added JINCS PV for PCDC. mr; 2/17/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173175","version":"1","longName":"Protocol","context":"Pediatric Cancer"},{"publicId":"12173182","version":"1","longName":"Subject Characteristics","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"DATA_CONTRIBUTOR_ID","type":"PCDC Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Data Source","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Incomplete","id":"F4E782A1-8C6E-2BDD-E053-731AD00ABF09","latestVersionIndicator":"Yes","beginDate":"2023-02-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-02-17","modifiedBy":"JKNABLE","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":"12/27/23 Change RS to Incomplete pending PV additions/updates per Nov 2023 PCDC-U of Chicago/Mei Li, part of Ped Cancer Core CDEs. jk;  3/9/23 upd definition for rep term. jk 2/17/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"}}